Lindsey A. George

5.0k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Lindsey A. George is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Lindsey A. George has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 22 papers in Hematology and 18 papers in Oncology. Recurrent topics in Lindsey A. George's work include Virus-based gene therapy research (24 papers), Hemophilia Treatment and Research (21 papers) and CAR-T cell therapy research (17 papers). Lindsey A. George is often cited by papers focused on Virus-based gene therapy research (24 papers), Hemophilia Treatment and Research (21 papers) and CAR-T cell therapy research (17 papers). Lindsey A. George collaborates with scholars based in United States, Australia and Canada. Lindsey A. George's co-authors include Benjamin J. Samelson‐Jones, Barry J. Byrne, Sanford L. Boye, Samiah Al-Zaidy, Stephanie Salabarria, Christine N. Kay, Kimberly Goodspeed, Louise R. Rodino‐Klapac, Steven J. Gray and Jerry R. Mendell and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Blood.

In The Last Decade

Lindsey A. George

32 papers receiving 1.3k citations

Hit Papers

Current Clinical Applicat... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindsey A. George United States 15 769 754 415 403 100 36 1.4k
Stephanie Laufs Germany 22 824 1.1× 574 0.8× 209 0.5× 394 1.0× 45 0.5× 59 1.3k
Giridhara R. Jayandharan India 27 1.6k 2.0× 1.2k 1.6× 489 1.2× 232 0.6× 160 1.6× 83 2.3k
Yunyu Spence United States 12 766 1.0× 827 1.1× 87 0.2× 306 0.8× 86 0.9× 16 1.1k
Hengjun Chao United States 11 706 0.9× 737 1.0× 103 0.2× 318 0.8× 128 1.3× 17 994
Christel Rivière France 11 520 0.7× 454 0.6× 158 0.4× 144 0.4× 101 1.0× 13 967
Luca Biasco Italy 15 757 1.0× 553 0.7× 181 0.4× 444 1.1× 22 0.2× 29 1.2k
Francesca Ficara Italy 16 1.2k 1.6× 786 1.0× 316 0.8× 633 1.6× 29 0.3× 43 1.9k
C. Anthony Blau United States 19 810 1.1× 492 0.7× 277 0.7× 336 0.8× 15 0.1× 47 1.3k
Fanny Collaud France 18 700 0.9× 705 0.9× 51 0.1× 239 0.6× 151 1.5× 32 1.1k
Samantha Scaramuzza Italy 17 520 0.7× 555 0.7× 106 0.3× 320 0.8× 33 0.3× 29 1.1k

Countries citing papers authored by Lindsey A. George

Since Specialization
Citations

This map shows the geographic impact of Lindsey A. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsey A. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsey A. George more than expected).

Fields of papers citing papers by Lindsey A. George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsey A. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsey A. George. The network helps show where Lindsey A. George may publish in the future.

Co-authorship network of co-authors of Lindsey A. George

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsey A. George. A scholar is included among the top collaborators of Lindsey A. George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsey A. George. Lindsey A. George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rasko, John E.J., Benjamin J. Samelson‐Jones, Lindsey A. George, et al.. (2025). Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study. New England Journal of Medicine. 392(15). 1508–1517. 5 indexed citations
2.
Doshi, Bhavya S., Robert J. Davidson, Wei Wang, et al.. (2025). Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies. Molecular Therapy. 33(7). 3073–3085. 2 indexed citations
3.
4.
Small, Juliana C., Sarah McCague, Sabrina W. Yum, et al.. (2025). Real-world outcomes of delandistrogene moxeparvovec gene therapy: Motor outcomes and emerging safety concerns. Molecular Therapy. 34(1). 123–130.
5.
Davidson, Robert J., et al.. (2024). Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice. Nature Communications. 15(1). 7193–7193. 11 indexed citations
6.
Samelson‐Jones, Benjamin J., Bhavya S. Doshi, & Lindsey A. George. (2024). Coagulation factor VIII: biological basis of emerging hemophilia A therapies. Blood. 144(21). 2185–2197. 4 indexed citations
7.
Samelson‐Jones, Benjamin J., Juliana C. Small, & Lindsey A. George. (2024). Roctavian gene therapy for hemophilia A. Blood Advances. 8(19). 5179–5189. 11 indexed citations
9.
George, Lindsey A., Bhavya S. Doshi, Denise E. Sabatino, et al.. (2023). Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo. Journal of Thrombosis and Haemostasis. 21(12). 3477–3489. 2 indexed citations
10.
Croteau, Stacy E., M. Elaine Eyster, Huyen Tran, et al.. (2022). Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011. Blood. 140(Supplement 1). 1899–1901. 5 indexed citations
11.
Samelson‐Jones, Benjamin J. & Lindsey A. George. (2022). Adeno-Associated Virus Gene Therapy for Hemophilia. Annual Review of Medicine. 74(1). 231–247. 79 indexed citations
12.
Samelson‐Jones, Benjamin J., et al.. (2021). Activated protein C has a regulatory role in factor VIII function. Blood. 137(18). 2532–2543. 20 indexed citations
13.
Konkle, Barbara A., Donna Coffin, Lindsey A. George, et al.. (2020). Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 18(11). 3074–3077. 35 indexed citations
14.
Mendell, Jerry R., Samiah Al-Zaidy, Louise R. Rodino‐Klapac, et al.. (2020). Current Clinical Applications of In Vivo Gene Therapy with AAVs. Molecular Therapy. 29(2). 464–488. 483 indexed citations breakdown →
15.
George, Lindsey A., Margaret V. Ragni, John E.J. Rasko, et al.. (2020). Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B. Molecular Therapy. 28(9). 2073–2082. 149 indexed citations
16.
Konkle, Barbara A., Donna Coffin, Glenn F. Pierce, et al.. (2020). World Federation of Hemophilia Gene Therapy Registry. Haemophilia. 26(4). 563–564. 36 indexed citations
17.
Samelson‐Jones, Benjamin J., Jonathan D. Finn, Lindsey A. George, Rodney M. Camire, & Valder R. Arruda. (2019). Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity. JCI Insight. 4(14). 35 indexed citations
18.
George, Lindsey A. & David T. Teachey. (2016). Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children. Pediatric Drugs. 18(4). 261–272. 13 indexed citations
19.
George, Lindsey A. & Patrick Fogarty. (2015). Gene therapy for hemophilia: past, present and future. Seminars in Hematology. 53(1). 46–54. 25 indexed citations
20.
Camire, Rodney M. & Lindsey A. George. (2015). Profile of efraloctocog alfa and its potential in the treatment of hemophilia A. Journal of Blood Medicine. 6. 131–131. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026